Kate Cahill

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. doi Pharmacological interventions for smoking cessation: an overview and network meta-analysis
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 5:CD009329. 2013
  2. doi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 4:CD006103. 2012
  3. doi Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews
    Jamie Hartmann-Boyce
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Addiction 108:1711-21. 2013
  4. ncbi An update on therapeutics for tobacco dependence
    Tim Lancaster
    University of Oxford, Cochrane Tobacco Addiction Review Group, Department of Primary Healthcare, Old Road, Headington, Oxford, OX3 7LF, UK
    Expert Opin Pharmacother 9:15-22. 2008
  5. ncbi A preliminary benefit-risk assessment of varenicline in smoking cessation
    Kate Cahill
    Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, Oxford, UK
    Drug Saf 32:119-35. 2009
  6. doi Nicotine replacement therapy for smoking cessation
    Lindsay F Stead
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 11:CD000146. 2012
  7. doi Pharmacological treatments for smoking cessation
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom2Cochrane Tobacco Addiction Group, University of Oxford, Oxford, United Kingdom
    JAMA 311:193-4. 2014
  8. doi Nicotine vaccines for smoking cessation
    Jamie Hartmann-Boyce
    Department of Primary Care Health Sciences, University ofOxford, Oxford, UK
    Cochrane Database Syst Rev 8:CD007072. 2012
  9. ncbi Stage-based interventions for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 11:CD004492. 2010
  10. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 12:CD006103. 2010

Detail Information

Publications13

  1. doi Pharmacological interventions for smoking cessation: an overview and network meta-analysis
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 5:CD009329. 2013
    ..Cytisine (a treatment pharmacologically similar to varenicline) is also licensed for use in Russia and some of the former socialist economy countries. Other therapies, including nortriptyline, have also been tested for effectiveness...
  2. doi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 4:CD006103. 2012
    ....
  3. doi Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews
    Jamie Hartmann-Boyce
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Addiction 108:1711-21. 2013
    ..It also provides an up-to-date overview of review findings in this area to date and summary statistics for cessation reviews in which meta-analyses were conducted...
  4. ncbi An update on therapeutics for tobacco dependence
    Tim Lancaster
    University of Oxford, Cochrane Tobacco Addiction Review Group, Department of Primary Healthcare, Old Road, Headington, Oxford, OX3 7LF, UK
    Expert Opin Pharmacother 9:15-22. 2008
    ..Recent evidence suggests that the nicotine-receptor partial agonist varenicline is at least as effective as nicotine replacement therapy and antidepressants...
  5. ncbi A preliminary benefit-risk assessment of varenicline in smoking cessation
    Kate Cahill
    Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, Oxford, UK
    Drug Saf 32:119-35. 2009
    ....
  6. doi Nicotine replacement therapy for smoking cessation
    Lindsay F Stead
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Cochrane Database Syst Rev 11:CD000146. 2012
    ....
  7. doi Pharmacological treatments for smoking cessation
    Kate Cahill
    Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom2Cochrane Tobacco Addiction Group, University of Oxford, Oxford, United Kingdom
    JAMA 311:193-4. 2014
    ..replacement therapy [NRT], bupropion, and varenicline), which is most effective in helping people who smoke achieve and maintain abstinence from smoking for at least 6 months, and what serious adverse events are associated with each?..
  8. doi Nicotine vaccines for smoking cessation
    Jamie Hartmann-Boyce
    Department of Primary Care Health Sciences, University ofOxford, Oxford, UK
    Cochrane Database Syst Rev 8:CD007072. 2012
    ..By reducing the amount of nicotine that reaches the brain when a person smokes a cigarette, nicotine vaccines may help people to stop smoking or to prevent recent quitters from relapsing...
  9. ncbi Stage-based interventions for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 11:CD004492. 2010
    ..People in the preparation and action stages of quitting would require different types of support from those in precontemplation or contemplation...
  10. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 12:CD006103. 2010
    ..The first trial reports of varenicline were released in 2006, and further trials have now been published or are currently underway...
  11. ncbi Nicotine receptor partial agonists for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 2:CD006103. 2011
    ..The first trial reports of varenicline were released in 2006, and further trials have now been published or are currently underway...
  12. doi Workplace interventions for smoking cessation
    Kate Cahill
    Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, UK, OX2 6GG
    Cochrane Database Syst Rev 2:CD003440. 2014
    ..The workplace has potential as a setting through which large groups of people can be reached to encourage smoking cessation...
  13. ncbi Competitions and incentives for smoking cessation
    Kate Cahill
    Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, UK, OX3 7LF
    Cochrane Database Syst Rev 4:CD004307. 2011
    ..Public health initiatives in the UK are currently planning to deploy incentive schemes to change unhealthy behaviours. Quit and Win contests are the subject of a companion review...